A Kakinada model for the world: How Dr Yanamadala Murali Krishna redefined long-term HIV care
A 25-year study by Dr. Yanamadala Murali Krishna from Andhra Pradesh reveals effective, long-term HIV treatment is achievable in low-income settings without costly drugs. His research, published in JIPAC, highlights an 88.3% survival rate using simplified regimens and continuous clinical evaluation, saving significant costs and dramatically reducing opportunistic infections. The doctor-patient relationship proved crucial for high adherence.
A 25-year study by Dr. Yanamadala Murali Krishna from Andhra Pradesh reveals effective, long-term HIV treatment is achievable in low-income settings without costly drugs. His research, published in JIPAC, highlights an 88.3% survival rate using simplified regimens and continuous clinical evaluation, saving significant costs and dramatically reducing opportunistic infections. The doctor-patient relationship proved crucial for high adherence.
